Home » Topics » Regulatory » Patents

Patents
RSS

New targets and treatments for cardiovascular disorders reported

May 11, 2005

New treatment option for macular degeneration disclosed by Nippon Soda

May 10, 2005

New therapeutics for cancer disclosed in recent patents

May 10, 2005

Schering-Plough discloses new therapeutic agents for erectile dysfunction

May 9, 2005

GSK discloses novel agents for renal and cardiovascular disorders and cancer

May 9, 2005

Novel agents for arthritis and other inflammatory disorders

May 9, 2005

Novel analgesic agents imparted by Neurogen, Euroceltique and Merz

May 9, 2005

Novel therapeutic agents for diabetes claimed in recent patents

May 6, 2005

Recent patents report new possible treatment options anxiety, depression, psychosis, etc.

May 6, 2005

Novel antithrombotic therapies claimed by Arena, Yamanouchi and Rovi

May 5, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...